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ReportRNA-Mediated Neurodegeneration
Caused by the Fragile X Premutation
rCGG Repeats in Drosophila
nell and Warren, 2002). Premutation alleles are ex-
tremely unstable during the germline transmission and
may expand into full mutations upon maternal transmis-
sion (Sherman, 2002).
Premutation carriers have long been considered phe-
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experience with fragile X families, the recognition of aEmory University
Atlanta, Georgia 30322 novel progressive neurodegenerative disorder has re-
cently been made in several male premutation carriers4 Department of Genetics
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Canada accompanied by memory and executive function defi-
cits, anxiety, and eventual dementia (Hagerman and
Hagerman, 2002). Postmortem examinations of the
brains of four such males revealed neuronal degenera-Summary
tion in the cerebellum and the presence of ubiquitin-
positive intranuclear inclusions in both neuronal andFragile X syndrome carriers have FMR1 alleles, called
premutations, with an intermediate number of 5 un- astrocytic nuclei of the cortex (Greco et al., 2002). The
emerging picture suggests a previously unrecognizedtranslated CGG repeats between patients (200 re-
peats) and normal individuals (60 repeats). A novel neurodegenerative phenotype in fragile X premutation
carriers more prevalent in males than females. Strikingly,neurodegenerative disease has recently been appreci-
ated in some premutation carriers. As no neurodegen- no evidence of neurodegeneration has been found in
either full mutation males or in the Fmr1 knockout mouseeration is seen in fragile X patients, who do not express
FMR1, we hypothesize that lengthened rCGG repeats model, indicating that modulation of FMRP levels un-
likely accounts for the neurodegeneration observed inof the premutation transcript may lead to neurodegen-
eration. Here, using Drosophila melanogaster, we these carriers. Since FMR1 premutation alleles are dis-
tinguished from both normal and full mutation alleles byshow that 90 rCGG repeats alone are sufficient to
cause neurodegeneration. This phenotype is neuron producing FMR1 transcripts with lengthy rCGG repeats,
it is possible that the neurodegeneration is RNA medi-specific and rCGG repeat dosage sensitive. Although
devoid of mutant protein, this neurodegeneration ex- ated. This notion, that rCGG abundance may be causal,
is further supported by observations that the FMR1hibits neuronal inclusion bodies that are Hsp70 and
ubiquitin positive. Overexpression of Hsp70 could sup- mRNA level is elevated in premutation carriers (Kenne-
son et al., 2001; Tassone et al., 2000). Thus, elevationpress the neurodegeneration. These results demon-
strate that neurodegenerative phenotype associated of FMR1 transcripts may work in concert with lengthy
rCGG repeats to cause neurodegeneration.with fragile X premutation is indeed caused by the
lengthened rCGG repeats and provide the first in vivo To test this hypothesis, we have established a Dro-
sophila model that ectopically expresses a portion ofexperimental demonstration of RNA-mediated neuro-
degeneration. the human FMR1 5 UTR containing either normal or
premutation-length rCGG repeats. We show that fragile
X premutation rCGG repeats alone can cause neurode-Introduction
generation in a dosage- and repeat length-dependent
manner. These results confirm the emerging clinical pic-Fragile X syndrome, a common form of inherited mental
retardation, is caused by a massive CGG trinucleotide ture of a novel neurodegenerative phenotype in some
premutation carriers and demonstrate that RNA alonerepeat expansion in the 5 UTR of the FMR1 gene that
leads to transcriptional silencing and the absence of the can cause the neurodegeneration.
encoded Fragile X Mental Retardation Protein (FMRP)
(O’Donnell and Warren, 2002). Most affected individuals Results
exhibit expansions of over 200 CGG repeats and are
referred to as full mutations. Among normal individuals, Expression of Fragile X Premutation rCGG
the CGG repeat is highly polymorphic in length and con- Repeats in Drosophila
tent with numerous alleles 60 repeats that are occa- To examine whether or not fragile X premutation-length
sionally interspersed with 1-3 AGG triplets (Kunst and rCGG repeats could cause neurodegeneration, we ex-
Warren, 1994). Intermediate alleles between 60 and 200 pressed human fragile X premutation rCGG repeats in
repeats are referred to as premutations with an esti- Drosophila melanogaster. Control of transgene expres-
mated prevalence of about 1 in 540 individuals (O’Don- sion and tissue specificity was achieved by the GAL4/
UAS (upstream activating sequence) system (Brand and
Perrimon, 1993). A human genomic FMR1 DNA fragment*Correspondence: swarren@emory.edu
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Figure 1. Expression of Fragile X Premutation rCGG Repeats
(A) Schematic representation of pUAST-(CGG)N-EGFP constructs. A human genomic FMR1 DNA fragment containing 90 CGG repeats was
inserted upstream of the EGFP coding region between the transcription and translation start sites. Both the transcription and translation start
sites are indicated. Two of the resulting transgenic lines did not maintain the repeat length of 90 but contracted the 3 end of the array,
resulting in a tract of 60 CGG repeats (UAS-(CGG)60-EGFP).
(B) Expression of (CGG)N-EGFP transgenes. RT-PCR was performed using the primers specific for the CGG repeat fragment, EGFP or Spen.
RNA and protein were isolated from the brains of flies: UAS-(CGG)N-EGFP/gmr-GAL4. Parental fly stock w1118 used to generate transgenic
flies was used as a negative control.
from a premutation carrier, containing 90 CGG repeats transgenic lines showed additional sequence variation
from the transforming construct. As a control, transgenic(with a commonly observed interruption pattern of AGG
triplets at repeat 10 and 20) and 200 base pairs of lines with the pUAST-EGFP vector alone were also gen-
erated.flanking sequence, was subcloned into the Drosophila
transformation vector pUAST-EGFP containing an en- To examine the expression of transgenes, we directed
expression to the retina using the gmr-gal4 driver (Free-hanced green fluorescent protein (EGFP) reporter gene
(Figure 1A). The CGG repeat fragment was inserted up- man, 1996). As shown in Figure 1B, RT-PCR using prim-
ers flanking the CGG repeat clearly show the repeat isstream of the EGFP coding region such that the tran-
scriptional start site preceded and the first translational transcribed in all lines, as do primers specific for the
EGFP coding sequence (with Split ends [spen] primersstart site followed the CGG repeat. No alternative ATG
translation start site is found between the transcription used as a positive control). In addition, the correct size
of transcript for each genotype was detected by North-start site and the CGG repeat. Five transgenic lines were
established with this construct, with all but two lines ern blot using EGFP cDNA as probe (data not shown).
Western analysis of the EGFP protein from all transgenicmaintaining 90 repeats. In the remaining two lines, the
3 end of the repeat array contracted, resulting in a 60 lines gave a product that appeared similar in size, indi-
cating the use of the same translational start site in allCGG repeat tract that maintained the AGG interruption
pattern (Figure 1A). By sequence analysis, none of the lines (Figure 1B). Overexposure of this blot revealed no
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Table 1. Effects of Targeted Expression Fragile X Premutation riboCGG Repeats to Different Tissues of Drosophila
(CGG)60-EGFP (CGG)90-EGFP (CGG)90-EGFP
GAL4 line Expression Pattern EGFP Moderate (CGG)60-EGFP Strong Moderate Strong
gmr-GAL4 All eye cells posterior No effect No effect Rough eye, loss of Mild rough eye and Rough eye, loss of
to the furrow pigmentation, and holes in the pigmentation, and
including holes in the tangential tangential sections severe cell death
photoreceptor sections
neurons and
pigment cells
elav-GAL4 All neurons of the No effect No effect Reduced viability Reduced viability Lethal
peripheral and
central nervous
system
Act5C-GAL4 Ubiquitous expression No effect No effect Late larval lethal Male lethality and Late larval lethal
in embryo reduced viability
in female
dpp-GAL4 Along the anterior- No effect No effect No effect No effect No effect
posterior boundary
of imaginal discs,
epithelial cells
additional bands. Less EGFP was observed with in- we did not observe significant difference of promoter
activity with dpp-GAL4 (data not shown). This indicatescreasing length of the CGG repeat, consistent with ear-
lier observations that migration of the 40S ribosomal that with similar expression level, rCGG appears more
toxic in neuronal than epithelial cells.subunit is impeded by a structure formed by the CGG
repeat and that there is a modest reduction in FMRP The severity of phenotype also appeared to be rCGG
repeat dosage and length dependent. When (CGG)60-levels from premutation alleles in human cells (Feng et
al., 1995; Kenneson et al., 2001; Primerano et al., 2002). EGFP was ubiquitously expressed at moderate levels
in the embryo by Act5C-GAL4, there was no effect, while
moderate expression of (CGG)90-EGFP led to male le-Dosage- and Repeat Length-Dependent Toxicity
thality and reduced viability in females despite the factof Fragile X Premutation rCGG
that both (CGG)60-EGFP and (CGG)90-EGFP were tran-To test whether or not the premutation rCGG repeat
scribed at a similar level (Table 1). Under the control ofproduced a phenotype, we directed transgene expres-
gmr-GAL4, moderate expression of (CGG)60-EGFP ap-sion to several tissues by crossing the lines to different
pears to have little effect on eye morphology and histol-GAL4 drivers. Transgene expression level was assessed
ogy, while moderate expression of (CGG)90-EGFP canby quantitative RT-PCR, and transgenic lines with both
lead, in either sex, to mild rough eye and small holes inmoderate and strong expressions were used for the
tangential sections of the eye (Figure 2, columns 2 andfollowing studies. In no case did expression of EGFP
4). Thus, similar to the observations in humans, moder-alone have an observed phenotypic effect (Table 1, Fig-
ate expression of a large normal CGG repeat (CGG)60 inure 2, column 1). In contrast, the expression of the pre-
Drosophila does not result in any phenotypes seen withmutation rCGG repeat, (CGG)90, had deleterious conse-
premutation allele (CGG)90. However, overexpression ofquences (Table 1). Strong expression of (CGG)90-EGFP
either the 60 or the 90 CGG repeats always led to aseverely disrupted eye morphology when expression
more severe phenotype, indicating that dosage as wellwas directed to the retina using gmr-GAL4 drivers (Table
as repeat length is important (Figure 2, columns 3 and 5).1, Figure 2, column 5). The fly retina is composed of
Compared to strong (CGG)60-EGFP expression, strongapproximately 800 virtually identical unit eyes, the om-
expression of (CGG)90-EGFP had more severe conse-matidia, which are arranged in a precise hexagonal array
quences, using both gmr-GAL4 and elav-GAL4, despitethat makes up the adult eye (Figure 2, UAS-EGFP; Hsi-
the fact that (CGG)90-EGFP was expressed at a lowerung and Moses, 2002). Expression of (CGG)90-EGFP led
level and overall rCGG repeat expression per se wasto dramatic cell death, loss of pigmentation, and omma-
lower (Table 1, Figure 2). Taking these results together,tidial disruption (Figure 2, column 5). When expression
we demonstrated that, similar to the human observation,was targeted to all developing cells of the peripheral
the fragile X premutation rCGG repeat indeed is patho-and central nervous system using elav-GAL4, strong
genic in Drosophila.expression of (CGG)90-EGFP caused lethality (Table 1;
Lin and Goodman, 1994). Ubiquitous expression of
(CGG)90-EGFP in the embryo using the Act5C-GAL4 line Fragile X Premutation rCGG Repeats Cause
Progressive Neurodegeneration in the Eyealso led to lethality at the late larval stage (Ito et al., 1997).
However, no phenotype was observed in any transgenic To determine if the rCGG-induced neurodegeneration
is progressive with age in Drosophila, we examined theline when expression was targeted to epithelial cells
using the dpp-GAL4 line. To determine if this apparent phenotypes caused by rCGG expression in the eyes of
the aged flies, which has been extensively used to modeldifferent tissue sensitivity is due to different GAL4 activ-
ity among driver lines, we crossed different driver lines other human neurodegeneration diseases (Muqit and
Feany, 2002; Warrick et al., 1998). We observed theto UAS-EGFP. Compared to gmr-GAL4 and elav-GAL4,
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Figure 2. Expressions of Fragile X Premutation rCGG Repeats Disrupt Eye Morphology in a Dosage- and Length-Dependent Manner
Column 1, flies expressing EGFP only; column 2, moderate expression of (CGG)60-EGFP; column 3, strong expression (CGG)60-EGFP; column
4, moderate expression of (CGG)90-EGFP; column 5, strong expression (CGG)90-EGFP. Genotypes are UAS-(CGG)N-EGFP in trans to gmr-
GAL4. All the flies shown here are 4 days old. Relative transgene expression levels determined by quantative RT-PCR (see Experimental
Procedures) are indicated at the top, and relative overall rCGG repeats were calculated by rCGG repeat size times relative transgene expression
level.
(A–E) SEM eye images.
(F–J) Light microscopic eye images. The areas with loss of pigmentation are indicated with arrow.
(K–O) Tangential sections through the eyes expressing different transgenes.
increased disruptions of eye morphology with the aged 29C (Figure 3D). No abnormality was observed with flies
expressing EGFP only (data not shown). These resultstransgenic flies expressing (CGG)90-EGFP from day 1 to
day 30 (data not shown). Since gmr-GAL4 line used here suggest that the phenotype that we observed is indeed
degenerative. Further, we tested the toxicity of fragiledrives expression in all cells of the developing and adult
eyes, including the photoreceptor neurons as well as X premutation rCGG repeats using a neuron-specific
GAL4 driver, elav-GAL4. Because high-level expressionaccessory pigment cells, we further examined whether
the progressive cell death we observed is truly neurode- of (CGG)90-EGFP led to lethality, we performed similar
cross to the above experiment using a moderate expres-generative rather than developmental (Ellis et al., 1993).
Using the UAS/GAL4 system allowed us to conditionally sion line of (CGG)90-EGFP. No eye abnormality was found
with flies at day 1 after eclosion or 4-day-old flies thatmodulate the promoter activity/transgene expression
level by shifting fly cultures to different temperatures. were maintained at 18C (Figures 3E and 3G). However,
the flies shifted to 29C displayed the loss of pigmenta-We used a moderate expression line of (CGG)90-EGFP
to set up the cross with gmr-GAL4 at 18C and maintain tion and disruption of eye structures (Figure 3F). Based
on these results, we conclude that, similar to humanit at this temperature until after eclosion (Figure 3A). No
abnormal eye structure was found at day 0 after eclosion male premutation carriers, expression of the rCGG re-
peat in Drosophila leads to progressive neurodegener-or 30-day-old flies that were maintained at 18C (Figure
3B and data not shown). The adult flies were transferred ation.
to 29C to increase transgene expression level and aged
(Figure 3A). Similar to the previous results, over the time, Premutation rCGG Repeats Induce the Formation
of Inclusion, and the Molecular Chaperone Hsp70the eyes showed progressive loss of pigmentation and
increased disruptions of ommatidia (Figure 3C). Indeed, Modifies the Neurodegeneration Phenotype
Since postmortem examination of the brains of four frag-by day 30, similar phenotype was observed as com-
pared to the strong expression lines that were kept at ile X premutation male patients with tremor/ataxia re-
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Figure 3. Fragile X Premutation rCGG Re-
peats Cause Neurodegeneration in Adult
Eyes
(A) The scheme used to study the effect of
rCGG repeats on adult eye. Flies were first
crossed and grown at 18C. After eclosion,
the flies were shifted to 29C to increase the
expression of rCGG repeats.
(B) The fly eye from day 0 after eclosion is
shown at left as control.
(C and D) Light microscopic eye images and
tangential sections from the aged (7 and 30
days) flies of (CGG)90-EGFP in trans to gmr-
GAL4.
(E and G) Light microscopic eye images and
tangential sections from the aged (4 days)
flies of elav-GAL4; (CGG)90-EGFP. The eyes
from day 0 after eclosion and the aged fly at
18C were shown as well.
vealed the presence of ubiquitin-positive intranuclear not found in control flies (expressing EGFP only), they
likely represent the nuclear inclusions observed in theinclusion, we examined the Drosophila eye strongly ex-
pressing (CGG)90-EGFP by immunohistochemistry using above immunohistochemistry experiments (Figure 4C).
These observations suggested that the premutationa panel of antibodies (Greco et al., 2002). Indeed, we
found the inclusions in the retina of 7-day-old flies, with rCGG repeat could induce the formation of nuclear inclu-
sions, as observed in humans.(CGG)90-EGFP in trans to gmr-GAL4. The inclusions were
positive for ubiquitin, Hsp70 chaperone, and the protea- Given that Hsp70 chaperone is part of the inclusions
induced by fragile X premutation rCGG repeats andsome, but negative for EGFP (Figure 4A and Supplemen-
tal Data at http://www.neuron.org/cgi/content/full/39/5/ Hsp70 has been shown to be a universal suppressors
of multiple human neurodegenerative models caused739/DC1). We further examined the subcellular localiza-
tion of these inclusions. Using both DAPI (stain for chro- by mutant proteins, we tested whether overexpression
of Hsp70 could alter the toxicity of rCGG repeats bymatin) and wheat germ agglutinin (label the nuclear
membranes), we found inclusions in both nuclei and generating the flies carrying both (CGG)90-EGFP and
UAS-HSC70-4.WT transgenes along with gmr-GAL4cytoplasm, which is different from postmortem analysis
of the four premutation brains examined to date (Figure (Elefant and Palter, 1999). To our surprise, coexpression
of fly Hsp70 could suppress rCGG-induced degenera-4B; Greco et al., 2002). To further examine the structure
and formation of inclusions, we performed transmission tion, even though no mutant protein is present (Figure
4D). In addition, the coexpression of a dominant-nega-electron microscopy using 7-day-old flies. Small and
morphologically distinct nuclear aggregates were found tive form of Hsp70-4.K71S with an amino acid substitu-
tion in the ATP binding domain could enhance the phe-in the nuclei of eye cells (Figure 4C). These small nuclear
aggregates were extremely electron dense and localized notype caused by rCGG repeats (Figure 4D; Elefant and
Palter, 1999). Very modest effect on the eye expressingclosely with each other. In some cells, large nuclear
inclusions could also be found, surrounded by small Hsp70-4.K71S only was observed (Figure 4D). This data
suggests that besides its role in the refolding of mis-aggregates. Since these electron-dense structures were
Neuron
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Figure 4. Fragile X Premutation rCGG Repeats Induce the Formation of Inclusions, and the Molecular Chaperone Hsp70 Suppresses rCGG
Repeat-Induced Neurodegeneration In Vivo
(A) Confocal images are shown of the brain sections from 7-day-old flies of either UAS-EGFP only or (CGG)90-EGFP in trans to gmr-GAL4,
stained with an antibody against Hsp70 (red). The nuclei were stained with DAPI (blue).
(B) Higher magnification of individual cells from the retina expressing (CGG)90-EGFP. The nuclei were stained with DAPI, and nuclear envelope
was labeled with wheat germ agglutinin-tetramethylrhodamine. Hsp70-postive inclusions are both nuclear and cytoplasmic.
(C) The transmission electron micrographs of 7-day-old fly eyes expressing EGFP only (left) or (CGG)90-EGFP (right). The nuclear inclusions
are indicated with an arrow.
(D) Shown are light level and SEM pictures of the eyes of 7-day-old flies expressing (CGG)90-EGFP only (left), with Hsp70-4.WT, with Hsp70-
4.K71S, and Hsp70-4.K71S only. The gmr-GAL4 driver was used.
folded protein, as a molecular chaperone, the activity vides the first experimental demonstration of RNA-medi-
ated neurodegeneration.of Hsp70 is a critical modulator of toxicity caused by
not only mutant proteins but also pathogenic RNAs,
although perhaps indirectly via unfolded proteins asso- RNA-Mediated Neurodegeneration
ciated with the rCGG repeat. Neurodegenerative diseases are a heterogeneous group
of disorders that usually strike in mid-life and include
the polyglutamine diseases, the tauopathies, and Par-Discussion
kinson’s disease (Zoghbi and Botas, 2002). Most of
these mutations are found within the coding region ofA progressive neurodegenerative syndrome has re-
cently been described in some fragile X premutation the relevant loci and share a common feature of misfold-
ing of the mutant proteins. However, several neurode-carriers. However, the molecular basis of this neurode-
generative disorder is unclear and indeed the link be- generative disorders, including Spinocerebellar ataxia
type 8, 10, 12, and Huntington’s disease-like type 2,tween the FMR1 premutation and neurodegeneration
has yet to be formally established by a prospective have been linked to noncoding repeat expansions (Ra-
num and Day, 2002). While the underlying mechanismsstudy. Here we presented a Drosophila model and dem-
onstrated that a fragile X premutation rCGG repeat alone for these disorders remains obscure, a toxic RNA-medi-
ated gain-of-function has been suggested along withis sufficient to cause neurodegeneration and induce the
formation of inclusions. These findings strongly support other possibilities. Apparently similar to these disorders
is the recently described neurodegenerative syndromethe emerging clinical picture of a novel neurodegenera-
tive disorder in humans carrying FMR1 premutation al- characterized by progressive intension tremor and
ataxia in fragile X premutation carriers (Hagerman et al.,leles. This Drosophila model, besides shedding insight
on the molecular basis of this neurodegeneration, pro- 2001). The common feature, besides neurodegenera-
RNA-Mediated Neurodegeneration
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tion, is the hypothetical link of a noncoding RNA-medi- ruling out the trivial explanation of our results by up-
stream promiscuous translation.) It has been well knownated neurodegeneration. Since full mutation patients
that long triplet repeats can form stable hairpin struc-with fragile X syndrome, who do not express FMR1 mes-
ture, and it is possible that the protein(s) interacting withsage, do not show evidence of neurodegeneration, the
long rCGG repeats (possible double-stranded RNA) maycausal focus has fallen upon the premutation message.
fold into a stable alternative conformation, which resultsUsing Drosophila as a model system, we demonstrate
in aggregation, and become the target for protein degra-here that indeed a portion of the human FMR1 5 UTR
dation (O’Donnell and Warren, 2002). In addition, Hsp70of a premutation allele containing 90 rCGG repeats is
may also confer the protection by inhibiting signal trans-alone sufficient to cause neurodegeneration. We further
duction pathways leading to cell death, by preventingshow that a normal CGG repeat of 60 triplets, when
activation of stress kinases, or by blocking pro-caspasemoderately expressed, has little phenotype, and this
processing or caspase activation (Gabai et al., 1997;same allele, when overexpressed, does lead to neurode-
Mosser et al., 2000; Zhou et al., 2001). Finally, this datageneration, supporting the notion that overall rCGG
implicating the role of protein degradation in RNA-medi-abundance is critical. Therefore, it is likely for the human
ated neurodegeneration links this form of neurodegen-disorder that a combination of CGG repeat length and
eration to the larger class of neurodegenerative dis-FMR1 message abundance together may define a
eases exhibiting features of protein misfolding (Boninithreshold for the clinical phenotype.
and Fortini, 2003; Soto, 2003; Zoghbi and Botas, 2002).
By inference of this Drosophila model, we might now
Formation of Inclusions Caused by rCGG Repeats
speculate that the human disorders linked to noncoding
The intriguing observation from the neuroanatomical
repeat loci are likely to involve RNA-mediated neurode-
studies on fragile X premutation carrier males with neu- generation and to share this overall feature of protein
rodegenerative phenotype is the presence of ubiquitin- misfolding, thus linking all human neurodegenerative
positive intranuclear neuronal inclusions (Greco et al., diseases together.
2002). The origin of the intranuclear inclusions is un-
known; however, some features are also observed with Molecular Pathogenesis of Neurodegeneration
the polyglutamine disorders. In this study, we showed Caused by rCGG Repeats
that fragile X premutation rCGG repeats not only cause Pathogenic RNAs that alter cellular functions have been
neurodegeneration but also induce the formation of in- previously associated with several human diseases (Ra-
clusions. The presence of ubiquitin and proteasome num and Day, 2002). In myotonic dystrophy type 1
complex within the inclusions suggests a role of the (DM1), a CTG expansion in the 3 UTR sequesters CUG
protein degradation pathway in the pathogenesis of this binding proteins from their normal cellular functions,
tremor/ataxia syndrome associated with fragile X pre- leading to abnormal RNA splicing of several genes (Ra-
mutation carriers. Interestingly, recent neurohistological num and Day, 2002). It is likely that fragile X premutation
studies on expanded-CGG repeat mouse also showed rCGG may behave similarly. In the fragile X premutation
the presence of ubiquitin-positive inclusions (Willemsen carriers with elevated FMR1 mRNA, the long rCGG tract
et al., 2003). These results suggest that high level of may attract and sequester rCGG binding protein(s) from
rCGG repeat can lead to the formation of inclusions. its normal functions, affect RNA metabolism, increase
One discrepancy between our fly model and human cellular toxicity, and lead to progressive cell death, par-
pathological study is the presence of inclusion in both ticularly in the brain since it has highest expression of
nuclei and cytoplasm in our fly model. However, in the FMR1 gene. Indeed, it has been shown that rCGG re-
expanded CGG repeat mouse model, both nuclear and peats could be bound by the proteins from mouse brain
cytoplasmic inclusions were also observed. This differ- (Rosser et al., 2002). Identification of these rCGG binding
ence may be human specific; however, in some polyglu- proteins will be important to test this hypothesis and
tamine diseases, such as Huntington disease, inclusions understand the pathogenesis of this novel disorder.
were also found present in both nuclei and cytoplasm In conclusion, we demonstrated that RNA alone is
(Li et al., 2000). Alternatively, it might be an age-related sufficient to cause neurodegeneration and that this form
phenomenon or disease state-dependent, since human of neurodegeneration shares the feature of protein mis-
pathological study was done using postmortem brains. folding involvement common to most other forms of
We also found that molecular chaperone, Hsp70, is a genetic neurodegeneration. These data also strongly
constituent of the inclusions, and variable expression support the emerging clinical picture of a specific neuro-
of Hsp70 could modify the degenerative phenotype in degenerative disease associated with fragile X premuta-
the eye. Studies in both flies and mice show that overex- tion carriers and suggest this disorder may exhibit a
pression of chaperones or HSPs, particularly Hsp70, clinical threshold based upon total rCGG abundance.
which help fold proteins or target them for degradation, Finally, based upon the data presented here, the power
increase resistance to polyglutamine-induced toxicity of Drosophila genetics can now be used to dissect the
(Chan et al., 2000, 2002; Cummings et al., 2001; Fernan- molecular basis of RNA-mediated neurodegeneration
through enhancer and suppressor screens and to testdez-Funez et al., 2000; Kazemi-Esfarjani and Benzer,
novel therapeutic approaches.2000; Warrick et al., 1999). However, in our fly model, the
CGG repeats were only transcribed but not translated,
Experimental Proceduresthere is no mutant protein to misfold and be a chaperone
target. (We note that CGG, in any reading frame, cannot Drosophila Genetics
code for polyglutamine nor is any polyglutamine de- The pUAST-EGFP construct was generated by cloning EGFP cDNA
in the pUAST transformation vector. The pUAST-(CGG)90-EGFP wastected immunohistochemically in the inclusions, thereby
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then generated by inserting a genomic DNA fragment (between Received: May 7, 2003
Revised: June 8, 2003primer C and F) from a fragile X premutation carrier upstream of the
EGFP cDNA (EcoRI site) in the pUAST-EGFP transformation vector. Accepted: August 12, 2003
Published: August 27, 2003The configuration of inserted CGG repeats is (CGG)9AGG(CG
G)9AGG(CGG)70. These constructs were confirmed by DNA sequenc-
ing and then injected in a w1118 strain by standard methods. The References
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